FibroBiologics Inc (NASDAQ: FBLG) is -87.64% lower on its value in year-to-date trading and has touched a low of $0.69 and a high of $6.06 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The FBLG stock was last observed hovering at around $0.71 in the last trading session, with the day’s gains setting it 249.27%.
Currently trading at $249.98K, the stock is -22.03% and -32.17% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 3.34 million and changing 3343335% at the moment leaves the stock -65.71% off its SMA200. FBLG registered -69.10% loss for a year compared to 6-month loss of -70.57%. The firm has a 50-day simple moving average (SMA 50) of $0.91128 and a 200-day simple moving average (SMA200) of $1.802505.
The stock witnessed a -20.03% gain in the last 1 month and extending the period to 3 months gives it a -39.40%, and is -11.14% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 10.14% over the week and 10.37% over the month.
FibroBiologics Inc (FBLG) has around 13 employees, a market worth around $23.65M and $0.00M in sales. Distance from 52-week low is -10.42% and -89.80% from its 52-week high. The company has generated returns on investments over the last 12 months (-238.48%).
The EPS is expected to shrink by -28.85% this year.
FibroBiologics Inc (FBLG) Top Institutional Holders
88.0 institutions hold shares in FibroBiologics Inc (FBLG), with institutional investors hold 21.46% of the company’s shares. The shares outstanding are 37.74M, and float is at 27.42M with Short Float at 4.91%. Institutions hold 16.86% of the Float.
The top institutional shareholder in the company is FUND EVALUATION GROUP, LLC with over 1.06 million shares valued at $5.26 million. The investor’s holdings represent 3.2247% of the FBLG Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 0.92 million shares valued at $4.59 million to account for 2.8086 of the shares outstanding. The other top investors are STATE STREET CORP which holds 0.38 million shares representing 1.1493% and valued at over $1.88 million, while GEODE CAPITAL MANAGEMENT, LLC holds 0.9649 of the shares totaling 0.32 million with a market value of $1.58 million.
FibroBiologics Inc (FBLG) Insider Activity
The most recent transaction is an insider purchase by Khoja Hamid, the company’s Chief Scientific Officer. SEC filings show that Khoja Hamid bought 20,000 shares of the company’s common stock on May 27 ’25 at a price of $0.84 per share for a total of $16800.0. Following the purchase, the insider now owns 31250.0 shares.
FibroBiologics Inc disclosed in a document filed with the SEC on Aug 12 ’24 that O’HEERON PETE (Chief Executive Officer) bought a total of 8,500 shares of the company’s common stock. The trade occurred on Aug 12 ’24 and was made at $1.91 per share for $16269.0. Following the transaction, the insider now directly holds 6.06 million shares of the FBLG stock.
Still, SEC filings show that on Aug 12 ’24, Khoja Hamid (Chief Scientific Officer) acquired 10,000 shares at an average price of $1.90 for $19000.0. The insider now directly holds 11,250 shares of FibroBiologics Inc (FBLG).
